Article · 21 Jul 2025
Conference abstractPublished 16 Sep 2020
Metabonomics discovery of a compound from the microbiome of a genetically modified mouse with anti-obesity properties
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Metabolic profiling or metabonomics is an important systems biology methodology for disease diagnosis and prognosis. It is also an excellent methodology for the phenotyping of genetically modified mice. We recently used this technology in collaboration with the group of Professor Elizabeth Shephard at UCL, to investigate the metabolic phenotype of a genetically modified mouse that had an unusual, lean phenotype. The genetic modification in this mouse caused a change in its microbiome, and the production by the microbiome, of a new metabolite X. We identified this compound by spectroscopic methods and subsequently showed it to have anti obesity properties and to be responsible for the lean clinical phenotype. This talk will provide an overview of this work and the properties of compound X.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Research Journal of Pharmacy and Pharmacology.
Article · 28 Mar 2025
Clinical Trials in Pharmacology: Bridging Research and Therapeutic Application
Article · 28 Mar 2025
Drug Formulation and Delivery Systems: Engineering Precision in Therapeutics
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Research Journal of Pharmacy and Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jeremy R. Everetta”
